All News ALK-Abelló A/S

Equities

ALK B

DK0061802139

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:59 2024-05-31 am EDT			5-day change	1st Jan Change
152.6 ^DKK	+1.60%		-1.10%	+50.79%

May. 30	Alk's European Registration Application for Itulazax for Pneumiatric Indication Accepted for Review	CI
May. 03	Transcript : ALK-Abelló A/S, Q1 2024 Earnings Call, May 03, 2024

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ALK Abelló A/S : European registration application for ITULAZAX® for paediatric indication accepted for review	May. 30	PU
ALK’s European registration application for ITULAZAX® for paediatric indication accepted for review	May. 30	GL
Alk's European Registration Application for Itulazax for Pneumiatric Indication Accepted for Review	May. 30	CI
ALK Abelló A/S : Listen in on ALK's Capital Markets Day on 4 June 2024	May. 29	PU
Listen in on ALK’s Capital Markets Day on 4 June 2024	May. 29	GL
Transcript : ALK-Abelló A/S, Q1 2024 Earnings Call, May 03, 2024	May. 03
ALK Abelló A/S : Three-month interim report (Q1) 2024 (unaudited)	May. 02	PU
Three-month interim report (Q1) 2024 (unaudited)	May. 02	GL
ALK-Abelló A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
ALK upgrades its full-year revenue outlook	May. 02	GL
ALK-Abelló A/S Updates Revenue Guidance for the Year 2024	May. 02	CI
ALK-Abelló A/S Provides Earnings Guidance for the Year 2024	May. 02	CI
ALK Abelló A/S : Invitation to the presentation of ALK's first quarter results on Friday 3 May 2024	Apr. 24	PU
Invitation to the presentation of ALK’s first quarter results on Friday 3 May 2024	Apr. 24	GL
Grant of share-based long-term incentive instruments to members of the Board of Management and key employees	Apr. 03	GL
ALK Abelló A/S : Save the date for ALK's Capital Markets Day on 4 June 2024	Mar. 26	PU
Save the date for ALK’s Capital Markets Day on 4 June 2024	Mar. 26	GL
Annual General Meeting in ALK-Abelló A/S held on 14 March 2024	Mar. 14	GL
Transcript : ALK-Abelló A/S - Shareholder/Analyst Call	Mar. 14
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff	Mar. 05	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ALK-Abelló A/S : No allergy on the horizon

March 12, 2024 at 10:20 am EDT